Neogenomics (NEO) Change in Accured Expenses (2010 - 2026)

Neogenomics (NEO) has reported Change in Accured Expenses for 17 consecutive years, with $718000.0 the latest figure, recorded in Q1 2026.

• Change in Accured Expenses for Q1 2026 came in at $718000.0, up 103.13% year-over-year; the trailing twelve-month figure through Mar 2026 was $19.0 million (up 170.79% YoY), and the FY2025 annual result was -$4.7 million, down 17.22% from the prior year.
• Change in Accured Expenses was $718000.0 for Q1 2026 at Neogenomics, down from $6.9 million in the prior quarter.
• Over five years, Change in Accured Expenses peaked at $30.7 million in Q2 2025 and troughed at -$23.0 million in Q1 2025.
• Average Change in Accured Expenses over 5 years is -$628411.8, with a median of -$138000.0 recorded in 2024.
• The widest YoY moves for Change in Accured Expenses: up 1531.4% in 2025, down 16535.51% in 2025.
• Over 5 years, Change in Accured Expenses stood at $1.8 million in 2022, then plunged by 184.21% to -$1.6 million in 2023, then plunged by 93.0% to -$3.0 million in 2024, then jumped by 328.85% to $6.9 million in 2025, then plunged by 89.56% to $718000.0 in 2026.
• Per Business Quant data, the three most recent Change in Accured Expenses figures were $718000.0 in Q1 2026, $6.9 million in Q4 2025, and -$19.3 million in Q3 2025.